首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1619082

体外诊断市场规模、份额、成长分析、按产品、按技术、按检体、按测试类型、按应用、按最终用户、按地区 - 行业预测，2024-2031 年

In-Vitro Diagnostics Market Size, Share, Growth Analysis, By Product (Reagents & Kits, Instruments), By Technology (Immunoassays, Clinical Chemistry), By Specimen, By Test Type, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球体外诊断市场规模预估为835亿美元，从2023年的879.3亿美元成长到2031年的1,329亿美元，预测期间（2024-2031年）复合年增长率为5.3%。

由于慢性病盛行率上升以及消费者对早期准确诊断解决方案的需求不断增加，体外诊断市场预计将成长。对医疗研发和技术进步的投资将进一步增强体外诊断公司的能力。此外，人口老化、疾病检测需求的快速增加以及个人化医疗的不断增长趋势为市场参与者提供了巨大的商机。然而，高昂的开发成本、严格的监管要求和有限的报销选择等挑战可能会阻碍长期需求。整体而言，相关人员需要驾驭这些动态，以充分利用 2023 年及以后体外诊断领域充满希望的成长前景。

市场概况
免疫检测
- 酵素免疫分析法测定法 (ELISA)
- 化学冷光免疫检测
- 萤光测定
- 快速测试
- 酵素连结免疫斑点测定法（Elispot）
- 蛋白质印迹法
- 其他的
临床化学
- 基础代谢组
- 肝臟组
- 肾臟概况
- 血脂谱
- 甲状腺功能检查
- 电解质板
- 特殊化学测试
分子诊断
- 聚合酵素链锁反应(PCR)
- 恒温核酸增幅技术（INAAT）
- DNA定序与次世代定序(NGS)
- 原位杂交（ISH）
- DNA微阵列
- 其他的
血液学
微生物学
凝血和止血
尿液检查
层析法和质谱分析

体外诊断市场规模：依检体及复合年增长率（2024-2031）

市场概况
血
血清
电浆
唾液
尿

体外诊断市场规模：依测试类型及复合年增长率（2024-2031）

市场概况
临床检查
就地检验

体外诊断市场规模：按应用和复合年增长率（2024-2031）

市场概况
感染疾病
肿瘤学
内分泌学
心臟病学
验血
基因检测
自体免疫疾病
过敏诊断
药物监测和检测
骨骼和矿物质疾病
血液凝固检验
血型分类
其他用途

体外诊断市场规模：依最终用户和复合年增长率（2024-2031）

市场概况
医院/诊所
临床实验室
血库
家庭护理设置
製药和生物技术公司
学术机构
其他最终用户

体外诊断市场规模及复合年增长率（2024-2031）

北美洲
- 美国
- 加拿大
欧洲
- 英国
- 德国
- 西班牙
- 法国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

Roche
Siemens Healthineers
Thermo Fisher Scientific
Abbott Laboratories
bioMerieux
Bio-Rad Laboratories
QIAGEN
Agilent Technologies
Sysmex Corporation
Fujifilm Holdings
Illumina
Shimadzu Corporation
DiaSorin
Grifols
Quest Diagnostics
Transasia Bio-Medicals
Tulip Diagnostics
NeoDx
Voxtur Bio
Peerless Biotech

结论和建议

简介目录

Product Code: SQSG35G2015

Global In-Vitro Diagnostics Market size was valued at USD 83.50 Billion in 2022 and is poised to grow from USD 87.93 Billion in 2023 to USD 132.90 Billion by 2031, growing at a CAGR of 5.3% during the forecast period (2024-2031).

The in-vitro diagnostics market is poised for growth, driven by the rising prevalence of chronic diseases and an increasing consumer demand for early and precise diagnostic solutions. Investments in medical research and development, along with advancements in technologies, will further enhance the capabilities of in-vitro diagnostics firms. Additionally, an aging population, a surge in disease testing requirements, and the growing trend towards personalized medicine present substantial opportunities for market players. Nonetheless, challenges such as high development costs, stringent regulatory requirements, and limited reimbursement options may hinder long-term demand. Overall, stakeholders should navigate these dynamics to capitalize on the promising growth landscape within the in-vitro diagnostics sector through 2023 and beyond.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In-Vitro Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In-Vitro Diagnostics Market Segmental Analysis

Global In-Vitro Diagnostics Market is segmented by Product, Technology, Specimen, Test Type, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits, Instruments, Data Management Software & Services. Based on Technology, the market is segmented into Immunoassays, Clinical Chemistry, Molecular Diagnostics, Hematology, Microbiology, Coagulation & Hemostasis, Urinalysis, Chromatography & Mass Spectrometry. Based on Specimen, the market is segmented into Blood, Serum, Plasma, Saliva, Urine. Based on Test Type, the market is segmented into Laboratory Tests, Point-Of-Care Tests. Based on Application, the market is segmented into Infectious Diseases, Oncology, Endocrinology, Cardiology, Blood Screening, Genetic Testing, Autoimmune Diseases, Autoimmune Diseases, Allergy Diagnostics, Drug Monitoring & Testing, Bone & Mineral Disorders, Coagulation Testing, Blood Group Typing, Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Blood Banks, Home Care Settings, Pharmaceutical & Biotechnology Companies, Academic Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market is significantly influenced by several key drivers. Rapid advancements in technology and the growing demand for early and accurate disease detection are paramount in propelling market growth. Additionally, the increasing prevalence of chronic and infectious diseases, along with the rise in patient awareness regarding health monitoring, further fuels the market. Government initiatives promoting healthcare access and investments in research and development also contribute to the expansion of this sector. Furthermore, the aging population, which demands advanced diagnostic solutions, is another critical factor driving the growth of the In-Vitro Diagnostics market globally.

Restraints in the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market faces several constraints that may hinder its growth. Factors such as stringent regulatory requirements, which vary significantly by region, can complicate the approval process for new diagnostic products. Furthermore, the high costs associated with research and development pose a significant barrier, particularly for smaller firms lacking substantial financial resources. Additionally, the increasing competition among established players and emerging startups can lead to market saturation, driving prices down and affecting profitability. Lastly, the ongoing challenges related to data privacy and cybersecurity in healthcare can create further obstacles for innovation and market expansion in the in-vitro diagnostics sector.

Market Trends of the Global In-Vitro Diagnostics Market

The Global In-Vitro Diagnostics market is experiencing a significant trend toward home care solutions, driven by increasing consumer demand for convenience and accessibility. This shift is prompting in-vitro diagnostics companies to innovate and develop user-friendly test kits designed for at-home use, negating the need for medical supervision. As healthcare systems evolve and patients seek personalized and immediate testing options, these developments represent a lucrative opportunity for manufacturers. By capitalizing on the growing popularity of homecare, the in-vitro diagnostics sector is poised for robust revenue growth, while also improving patient engagement and outcomes on a global scale.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Driver & Opportunities
- Restraints & Challenges
Porters Analysis & Impact
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies
Customer & Buying Criteria Analysis

Global In-Vitro Diagnostics Market Size by Product & CAGR (2024-2031)

Market Overview
Reagents & Kits
Instruments
Data Management Software & Services

Global In-Vitro Diagnostics Market Size by Technology & CAGR (2024-2031)

Market Overview
Immunoassays
- Enzyme-Linked Immunosorbent Assays (ELISA)
- Chemiluminescence Immunoassays
- Immunofluorescence Assays
- Rapid Tests
- Enzyme-Linked Immunospot Assays (Elispot)
- Western Blotting
- Other
Clinical Chemistry
- Basic Metabolic Panels
- Liver Panels
- Renal Profiles
- Lipid Profiles
- Thyroid Function Panels
- Electrolyte Panels
- Specialty Chemical Tests
Molecular Diagnostics
- Polymerase Chain Reaction (PCR)
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Sequencing & Next-Generation Sequencing (NGS)
- In Situ Hybridization (ISH)
- DNA Microarrays
- Other
Hematology
Microbiology
Coagulation & Hemostasis
Urinalysis
Chromatography & Mass Spectrometry

Global In-Vitro Diagnostics Market Size by Specimen & CAGR (2024-2031)

Market Overview
Blood
Serum
Plasma
Saliva
Urine

Global In-Vitro Diagnostics Market Size by Test Type & CAGR (2024-2031)

Market Overview
Laboratory Tests
Point-Of-Care Tests

Global In-Vitro Diagnostics Market Size by Application & CAGR (2024-2031)

Market Overview
Infectious Diseases
Oncology
Endocrinology
Cardiology
Blood Screening
Genetic Testing
Autoimmune Diseases
Autoimmune Diseases
Allergy Diagnostics
Drug Monitoring & Testing
Bone & Mineral Disorders
Coagulation Testing
Blood Group Typing
Other Applications

Global In-Vitro Diagnostics Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals & Clinics
Clinical Laboratories
Blood Banks
Home Care Settings
Pharmaceutical & Biotechnology Companies
Academic Institutes
Other End Users

Global In-Vitro Diagnostics Market Size & CAGR (2024-2031)

North America, (Product, Technology, Specimen, Test Type, Application, End User)
- US
- Canada
Europe, (Product, Technology, Specimen, Test Type, Application, End User)
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific, (Product, Technology, Specimen, Test Type, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
Latin America, (Product, Technology, Specimen, Test Type, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa, (Product, Technology, Specimen, Test Type, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DiaSorin
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transasia Bio-Medicals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tulip Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeoDx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Voxtur Bio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Peerless Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments